Merck’s stock rallies toward a record after FDA OKs arterial-hypertension drug
Summary by MarketWatch
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left0Leaning Right0Center1Last Updated2 months agoBias Distribution100% Center